infectious-diseases

Documents about infectious-diseases

• Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection#491768eScholarship
• Equipment procurement for laboratory of environmental protection sector （Batch No.3） — China Emerging Infectious Diseases Prevention, Preparedness and Response Project (China)#606584World Bank
• Culture-enriched metagenomic sequencing reveals within-patient diversity and transmission of vancomycin-resistant Enterococcus faecium#10191bioRxiv / medRxiv
• DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia#121392ClinicalTrials.gov
• Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials#127676ClinicalTrials.gov
• PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria#146245ClinicalTrials.gov
• Host Factors Modulate Nirmatrelvir-Ritonavir Efficacy in COVID-19 Patients: A Viral Dynamics Modeling Study#152654bioRxiv / medRxiv
• Control and prevention of infectious diseases from a One Health perspective#163573WIPO
• COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study#172383ClinicalTrials.gov
• Establishment of Contextually Appropriate Cut Offs for Orthopoxvirus Serologic Assays in an Mpox-Endemic Setting#180169bioRxiv / medRxiv
• Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults#180195ClinicalTrials.gov
• Frailty, Geriatric Syndromes and Care Pathways of Older Adults Living With HIV in West Africa#184705ClinicalTrials.gov
• H5N1 With or Without Topical Aldara in Healthy Adults#184909ClinicalTrials.gov
• Local prevalence of ceftriaxone resistance informs optimal deploy-ment of new gonorrhea treatments#221600bioRxiv / medRxiv
• Development of an original algorithm to characterize serological antibody response that improve infectious diseases surveillance#221606bioRxiv / medRxiv
• A Safety and Immune Response Study of 2 Experimental HIV Vaccines#279575ClinicalTrials.gov
• Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults#303566ClinicalTrials.gov
• A Cost-Sensitive Behavioral Modeling Analysis of the Early Identification and Control of Infectious Diseases.#320624NCBI PubMed Central
• Borderless battles: Modelling the spread of artemisinin partial resistance in connected subpopulations in southern Africa#339594bioRxiv / medRxiv
• Projected population level impact and cost-effectiveness of clinic and community-based tuberculosis screening approaches#361572bioRxiv / medRxiv
• Clinical Study Protocol of the 'Biomarkers of Severity of COVID-19 Patients' (BIOMARCOVID) Project#373578bioRxiv / medRxiv
• Safety and Immune Response to a Clade C DNA HIV Vaccine#377278ClinicalTrials.gov
• Acceptability of and confidence in novel tuberculosis vaccines among South African adults living with HIV#448086bioRxiv / medRxiv
• Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults#448315ClinicalTrials.gov
• Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis#451506ClinicalTrials.gov
• Nationwide Mpox Genomic Surveillance Reveals Clade Ib Introductions, APOBEC3-Driven Evolution, and Terminal Deletions#456622bioRxiv / medRxiv
• Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine#459954ClinicalTrials.gov
• RSV concentration in wastewater and trends among incident hospitalizations in children and older adults#474708bioRxiv / medRxiv
• 42 U.S.C. § 300ff-131 — Infectious diseases and circumstances relevant to notification requirements#594616US Code (LII)
• Causes and Consequences of Emerging and Exotic Diseases of Animals: Role of the Veterinarian#239246Iowa State University Digital Repository
• Characterization and control of emerging viral diseases in Cambodia : insights from bat coronaviruses and chikungunya virus#333872HAL (France)
• Using Qualitative Research in Community Engagement to Capture and Mitigate Vulnerability Mechanisms in the Face of Infectious Diseases: Insights From a Research-Based Program in Five European Countries During the COVID-19 Pandemic#301172HAL (France)
• A "paradox of progress" shapes the social determinants of infectious diseases in Vietnam, 1975-2025#5691Europe PMC
• The pitfalls of incidence-based time series regression for inferring the effects of weather on infectious diseases#10141bioRxiv / medRxiv
• Diagnosis of Infectious Diseases using Nano Sensors Network in Nanofluids#14230HAL (France)
• Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children#18634ClinicalTrials.gov
• Behavioural determinants of testing behaviour during a hypothetical avian influenza outbreak: an interview study#18862bioRxiv / medRxiv
• Machine Learning Enabled Smartphone CRISPR-Cas12a Lateral Flow Platform for Sensitive Detection of Circulating HPV DNA#28632bioRxiv / medRxiv
• Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"#121402ClinicalTrials.gov
• Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load#121430ClinicalTrials.gov
• From multiplicity of infection to force of infection in sparsely sampled high-transmission Plasmodium falciparum populations#127862bioRxiv / medRxiv
• Artificial intelligence at the frontlines: Emerging infectious and parasitic diseases in the digital era.#136099PubMed
• Evaluating Heterologous-Insert Prime-Boost HIV Vaccine Regimens in HIV-Uninfected Adults#136425ClinicalTrials.gov
• Antibiotic Pharmacokinetics and Prostate Penetration in Bacterial Prostatitis: A Systematic Review#145134Springer Nature OA
• Local habitual movement as a mechanism for Schistosoma mansoni transmission resurgence - a causal analysis#158275bioRxiv / medRxiv
• Chikungunya Virus Vaccine Trial in Healthy Adults#180224ClinicalTrials.gov
• Multi-species plasmids and K. pneumoniae clonal spread driving blaNDM outbreak across seven UK healthcare sites#192344bioRxiv / medRxiv
• Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine#201623ClinicalTrials.gov
• Brachyspira species from swine#212923Figshare
• Risk Factors for Antimicrobial Resistance in Cancer Patients and Cancer Survivors: An Electronic Health Record Study#222349bioRxiv / medRxiv